Eight in 10 infants received respiratory syncytial virus (RSV) protection during the 2023 to 2024 season, according to a ...
The FDA will require GSK and Pfizer to include on the label of their respiratory syncytial virus (RSV) vaccines a warning ...
Barré syndrome, although it said data don’t prove a causal link and affirmed the shots’ benefit outweighs their risks.
In China, reports of HMPV infections have indeed been rising in recent weeks in the more northerly regions. But so have ...
For most people RSV is like a cold, but for infants and older people it can lead to serious infections. Here's what to know.
Vaccines and monoclonal antibodies are reducing RSV hospitalizations, but high costs and limited access in low-income ...
RSV causes respiratory symptoms ranging from mild, cold-like discomfort to illnesses like bronchiolitis or pneumonia ...
The CDC’s overall snapshot of respiratory illness activity in Florida remains very high. The CDC has measured moderate levels ...
The RSVpreF vaccine demonstrated 91% effectiveness against RSV-related lower respiratory tract disease in older adults during ...
And now, the human metapneumovirus, or HMPV for short, is infecting thousands of Americans around the country. The highly ...